Show simple item record

dc.contributor.advisorKale, Andrea
dc.contributor.authorCavender, Cole
dc.contributor.authorCastaneda, Luciano
dc.contributor.authorNguyen, Steven
dc.date.accessioned2019-05-03T20:59:08Z
dc.date.available2019-05-03T20:59:08Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/10150/632201
dc.descriptionClass of 2018 Abstracten_US
dc.description.abstractSpecific Aims: To determine if the response rate will be greater than the 14% response rate that was shown in the AUDIT study in 2006. The rationale is since statin therapy is recommended as part of the American Diabetes Association (ADA) guidelines, physicians will be more open to the suggestion and the response rate will be higher. Our secondary analysis is that at least an additional 5% of patients will be on statin therapy even though their physician did not respond to the fax. The rationale is that even though a physician may not respond to us via fax, they may be prompted to evaluate statin therapy for their patient and write a prescription for statin therapy. Subjects: Using Albertson’s pharmacy database, patients between the ages of 40 to 75 on metformin were filtered. Methods: This before/after study with independent groups used data obtained from a manual fax and compared the response to a previous study that was done in 2006. Main Results: A total of 26 faxes were sent out to providers notifying them that their patient qualified for statin therapy. A total of 4 responses were received with 1 patient that was appropriately initiated on statin therapy. Conclusions: There were no differences in physician response rates in our study compared to the AUDIT study with recommending statin therapy in patients 40 to 75 with type 2 diabetes mellitus that qualify for statin therapy per ADA guidelines.en_US
dc.language.isoen_USen_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author.en_US
dc.subjectstatin therapyen_US
dc.subjectADA guidelinesen_US
dc.subjectmetforminen_US
dc.subjectdiabetesen_US
dc.subjectAUDIT studyen_US
dc.subject.meshHydroxymethylglutaryl-CoA Reductase Inhibitorsen_US
dc.subject.meshMetforminen_US
dc.subject.meshDiabetes Mellitus, Type 2en_US
dc.titlePhysician Response to Pharmacist Statin Therapy Recommendations for Type 2 Diabetes Patientsen_US
dc.typetexten_US
dc.typeElectronic Reporten_US
dc.contributor.departmentCollege of Pharmacy, The University of Arizonaen_US
dc.description.collectioninformationThis item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.en_US


This item appears in the following Collection(s)

Show simple item record